Birch Grove Capital LP recently filed their 13F report for the first quarter of 2022, which ended on 2022-03-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
660 Madison Avenue, 15th Floor New York, NY 10065
As of the latest 13F report, the guru’s equity portfolio contained 18 stocks valued at a total of $33,000,000. The top holdings were STRY(25.90%), NOTV(23.21%), and DHT(8.66%).
According to GuruFocus data, these were Birch Grove Capital LP’s top five trades of the quarter.
Starry Group Holdings Inc
The guru established a new position worth 757,412 shares in NYSE:STRY, giving the stock a 25.9% weight in the equity portfolio. Shares traded for an average price of $8.64 during the quarter.
On 05/19/2022, Starry Group Holdings Inc traded for a price of $8.37 per share and a market cap of $1,391,075,000. The stock has returned 0.00% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Starry Group Holdings Inc has a price-book ratio of 31.39, a EV-to-Ebitda ratio of -20.13 and a price-sales ratio of 36.57.
Churchill Capital Corp VI
The guru sold out of their 400,000-share investment in NYSE:CCVI.U. Previously, the stock had a 8.54% weight in the equity portfolio. Shares traded for an average price of $9.91 during the quarter.
On 05/19/2022, Churchill Capital Corp VI traded for a price of $9.8 per share and a market cap of $0. The stock has returned -2.58% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, Churchill Capital Corp VI has a price-book ratio of 1.33.
Churchill Capital Corp V
The guru sold out of their 400,000-share investment in NYSE:CCV. Previously, the stock had a 8.44% weight in the equity portfolio. Shares traded for an average price of $9.79 during the quarter.
On 05/19/2022, Churchill Capital Corp V traded for a price of $9.8 per share and a market cap of $612,500,000. The stock has returned -1.01% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, Churchill Capital Corp V has a price-earnings ratio of 326.33, a price-book ratio of 1.33 and a EV-to-Ebitda ratio of 24.58.
Churchill Capital Corp VII
Birch Grove Capital LP reduced their investment in NYSE:CVII.U by 320,000 shares. The trade had a 6.87% impact on the equity portfolio. During the quarter, the stock traded for an average price of $9.87.
On 05/19/2022, Churchill Capital Corp VII traded for a price of $9.8 per share and a market cap of $0. The stock has returned -1.85% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, Churchill Capital Corp VII has a price-book ratio of 1.29.
Biomarin Pharmaceutical Inc
The guru sold out of their 30,850-share investment in NAS:BMRN. Previously, the stock had a 5.84% weight in the equity portfolio. Shares traded for an average price of $83.79 during the quarter.
On 05/19/2022, Biomarin Pharmaceutical Inc traded for a price of $79.58 per share and a market cap of $14,653,481,000. The stock has returned 0.66% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 3 out of 10.
In terms of valuation, Biomarin Pharmaceutical Inc has a price-earnings ratio of 440.04, a price-book ratio of 3.34, a EV-to-Ebitda ratio of 93.19 and a price-sales ratio of 7.89.
The price-to-GF Value ratio is 0.92, earning the stock a GF Value rank of 7.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
